Lexpos News

/Lexpos News/

New NHS.net Connect Launchpad homepage – rolling out

NHS.net Connect is replacing NHSmail, as announced previously. As part of this change, many community pharmacy teams will soon see a new NHS.net homepage called the Launchpad. The move to NHS.net Connect introduces a refreshed look and some improved features. The aim is to make communication and collaboration across the NHS easier. What is the [...]

The post New NHS.net Connect Launchpad homepage – rolling out appeared first on Community Pharmacy England.

By |April 22nd, 2026|Lexpos News|Comments Off on New NHS.net Connect Launchpad homepage – rolling out

Data Security and Protection Toolkit 2026: Are you working through it?

Deadline upcoming Community Pharmacy England previously published updated guidance and support to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. Completing the Toolkit is how pharmacies make their annual information governance (IG) declaration. It is a mandatory requirement under the NHS Terms of Service and must be completed by 30th [...]

The post Data Security and Protection Toolkit 2026: Are you working through it? appeared first on Community Pharmacy England.

By |April 22nd, 2026|Lexpos News|Comments Off on Data Security and Protection Toolkit 2026: Are you working through it?

SSP for Ramipril 1.25mg capsules extended

Update 28/05/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Ramipril 1.25mg capsules (SSP087) was due to expire 29 May 2026 but has been further extended to Friday 24 July 2026. In response to a significant ongoing disruption to the supply of Ramipril [...]

The post SSP for Ramipril 1.25mg capsules extended appeared first on Community Pharmacy England.

By |April 22nd, 2026|Lexpos News|Comments Off on SSP for Ramipril 1.25mg capsules extended

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd)

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]

The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.

By |April 22nd, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd)

April 2026 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (21/04/2026) confirmed the following list of price concessions for April 2026: Drug Pack size Price concession Amantadine 100mg capsules 56 £2.86 Apixaban 5mg tablets 56 £2.80 Aripiprazole 30mg tablets 28 £1.74 Aspirin 75mg dispersible tablets 28 £2.83 Aspirin 75mg dispersible tablets 100 £10.10 Atomoxetine 60mg capsules [...]

The post April 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |April 21st, 2026|Lexpos News|Comments Off on April 2026 Price Concessions 2nd Update